Data / Drug companies / Misemer Pharmaceuticals, Inc.
Misemer Pharmaceuticals, Inc.: 11 products in the FDA NDC directory, labeler code 0276
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Misemer Pharmaceuticals, Inc. (labeler code 0276) lists 11 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 10 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on May 23, 2025.
The request: Watch Misemer Pharmaceuticals, Inc. (FDA labeler code 0276): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0276
- Products in commercial distribution
- 11
- Packages
- 11
- Finished drugs by generic name
- 7
- Prescription products
- 10
- Over the counter products
- 1
- Controlled substance products
- Schedule IV 1
- Flagged as original packager
- 11 of 11 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- June 19, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 10 | 90.9% |
| Over the counter monograph drugs | 1 | 9.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 10 | 90.9% |
| Over the counter drugs | 1 | 9.1% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Fenoprofen calcium | 3 | 6 |
| Ketoprofen | 3 | 5 |
| Mefenamic acid | 1 | 5 |
| Polyethylene glycol 400, tetrahydrozoline hcl | 1 | 4 |
| Methocarbamol | 1 | 67 |
| Metaxalone | 1 | 38 |
| Chlordiazepoxide hydrochloride, clidinium bromide | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 8 | 72.7% |
| Solution/ drops | 1 | 9.1% |
| Tablet, coated | 1 | 9.1% |
| Tablet | 1 | 9.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ketoprofen | 0276-0507 | Capsule | Generic drugs (ANDA) | May 23, 2025 |
| Fenoprofen Calcium | 0276-0503 | Capsule | Generic drugs (ANDA) | November 1, 2023 |
| Fenoprofen Calcium | 0276-0502 | Capsule | Generic drugs (ANDA) | November 1, 2023 |
| Fenoprofen Calcium | 0276-0501 | Capsule | Generic drugs (ANDA) | November 1, 2023 |
| Glitch Advanced Relief Eye Drops | 0276-0801 | Solution/ drops | Over the counter monograph drugs | August 21, 2023 |
| Methocarbamol | 0276-0510 | Tablet, coated | Generic drugs (ANDA) | September 13, 2022 |
| Ketoprofen | 0276-0506 | Capsule | Generic drugs (ANDA) | September 13, 2022 |
| Mefenamic Acid | 0276-0509 | Capsule | Generic drugs (ANDA) | November 1, 2021 |
| Metaxalone | 0276-0508 | Tablet | Generic drugs (ANDA) | November 1, 2021 |
| Chlordiazepoxide Hydrochloride and Clidinium Bromide | 0276-0500 | Capsule | Generic drugs (ANDA) | September 3, 2020 |
| Ketoprofen | 0276-0504 | Capsule | Generic drugs (ANDA) | June 19, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.